News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Some AstraZeneca PLC Investors Want CEO Replaced
April 9, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
(Reuters) - Some of AstraZeneca's biggest investors are calling for a radical shake-up of the drugmaker's board and executive team, including the replacement of David Brennan as CEO, the Financial Times reported on Monday.
Twitter
LinkedIn
Facebook
Email
Print
People
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
Neurodegenerative disease
VectorY Bets up to $1.2B+ That Shape’s Brain-Penetrant Capsids Are a Fit
September 18, 2025
·
2 min read
·
Dan Samorodnitsky
Layoffs
Layoffs From Just 6 Pharmas Could Wipe Out Over 39,000 Jobs
September 18, 2025
·
9 min read
·
Angela Gabriel
PODCAST
What Do AI and Hammers Have in Common?
September 18, 2025
·
1 min read
·
Lori Ellis
Layoffs
Novo, BMS Layoffs Hit New Jersey Hard With More Than 500 Left Jobless
September 18, 2025
·
2 min read
·
Tristan Manalac
